Brendan Chambers Executive with First Citizens Bank, joins Michael Toglia, Publisher of ABL Advisor, for an in-depth discussion on First Citizens Bank’s strategic positioning within the middle market.

Expansion and extension of its senior secured credit facility, increasing the total borrowing capacity from $750 million to $825 million. The facility is comprised of a $725 million revolving credit ...

Alex McKeown and Dominick Keefe of Hilco Consumer-Retail and Restore Capital join Publisher of ABL Advisor, for an in-depth ...

Serving Asset-Based Lending Decision Makers The customized credit facility will provide Kizik with increased liquidity and financial f lexibility to support its rapid growth, continued product ...

The International Finance Corporation (IFC), a member of the World Bank Group, has announced a $50 million follow-on investment in Victory Park Capital Investor Fund W, LP (the “Fund”), reinforcing ...

Adam Duso of Second Wind Consultants and Curtis Powell of nFusion Capital meet with Michael Toglia of ABL Advisor to explore ...

SSG Capital Advisors served as the investment banker to The Warrell Corporation (“Warrell” or the “Company”) in the sale of its equity interests and owned real estate to Wolfgang Operations, LLC, and ...

Wells Fargo Leads $600MM Credit Facility for Arevon Energy to Accelerate Renewable Energy Growth ...

TAB Bank provided a $2.5 million factoring facility to Ryan Transportation, Inc., a Livonia, Michigan-based truckload transportation provider. The facility will strengthen cash flow and working ...

Solifi announced the acquisition of Leasepath, a leading middle-market provider of global equipment finance loan and lease management technology. This strategic acquisition accelerates Solifi’s ...

Capital Corp. announced the recent appointment of Jeff Butts, senior vice president, supply chain finance, within its commercial finance division. The move supports eCapital’s ongoing strategy to ...

Dyne Therapeutics, a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, entered into a $275 million non-dilutive ...